Table 5.
Low (n = 77) | High (n = 22) | P-value | |
---|---|---|---|
WBC† | 5.83 (1.42) | 6.02 (1.39) | 0.584 |
WBC group (≥ 10)‡‡ | 1.30% (1/77) | 0.00% (0/22) | 1.000 |
RBC† | 4.51 (0.37) | 4.43 (0.34) | 0.355 |
RBC group (≥ 5.40)‡‡ | 6.49% (5/77) | 9.09% (2/22) | 0.650 |
Hgb†† | 13.70 (12.80, 14.30) | 13.60 (12.65, 14.05) | 0.426 |
Hgb group (< 12)‡‡ | 2.60% (2/77) | 4.55% (1/22) | 0.534 |
Hct† | 40.71 (3.11) | 39.96 (2.74) | 0.315 |
Hct group (≤ 36)‡‡ | 3.90% (3/77) | 9.09% (2/22) | 0.307 |
Platelet† | 262.90 (47.60) | 269.32 (51.68) | 0.589 |
PLR†† | 82.87 (30.38) | 86.88 (32.68) | 0.749 |
PLR group (≥ 142.76 (F), ≥ 122.73 (M))‡‡ | 3.90% (3/77) | 4.55% (1/22) | 1.000 |
NLR†† | 1.13 (0.76) | 1.25 (0.83) | 0.614 |
NLR group (≥ 1.662 (F), ≥ 1.634 (M))‡‡ | 15.58% (12/77) | 27.27% (6/22) | 0.222 |
dNLR† | 1.40 (0.53) | 1.47 (0.62) | 0.601 |
LMR†† | 5.10 (3.93, 6.26) | 4.83 (3.84, 5.68) | 0.711 |
LMR group (≤ 5.598 (F), ≤ 5.048 (M))‡ | 33.77% (26/77) | 31.82% (7/22) | 1.000 |
SII†† | 249.58 (171.78, 356.45) | 255.39 (181.97, 399.05) | 0.668 |
ESR (mm/h)†† | 5.00 (2.00, 10.00) | 9.00 (4.25, 14.75) | 0.440 |
CRP (mg/L)†† | 0.04 (0.02, 0.08) | 0.05 (0.04, 0.08) | 0.354 |
RF‡‡ | 1.30% (1/76) | 4.50% (1/22) | 0.400 |
FANA‡ | 29.90% (23/77) | 18.20% (4/22) | 0.416 |
Anti-CCP‡‡ | 3.90% (3/77) | 0.00% (0/22) | 1.000 |
Total protein (g/dL)†† | 7.40 (7.1, 7.7) | 7.30 (7.0, 7.58) | 0.660 |
WBC: White blood cell, RBC: Red blood cell, Hgb: Hemoglobin, Hct: Hematocrit, PLR: Platelet-to-lymphocyte ratio, NLR: Neutrophil-lymphocyte ratio, dNLR: derived neutrophil-lymphocyte ratio, LMR: Lymphocyte-monocyte ratio, SII: Systemic inflammatory index, ESR: Erythrocyte sedimentation rate, CRP: C-reactive protein, RF: Rheumatoid factor, FANA: Fluorescent antinuclear antibody, anti-CCP: anti-cyclic citrullinated peptide
†Differences between groups were tested with independent t-test: mean (standard deviation)
††Differences between groups were tested with Mann-Whitney test: median (lower quartile, upper quartile)
‡Differences between groups were tested with chi-square test: number of subjects or positive palpation sites (%)
‡‡Differences between groups were tested with Fisher’s exact test: number of subjects or positive palpation sites (%)
*Significant difference, p < 0.05